Plateaus: what is happening, and what helps

First, the thing we say before anything else

A plateau is not a verdict. It is not evidence that you did something wrong, that you have been secretly undoing your own efforts, or that the medicine has decided you are not trying hard enough. Ada, who holds the plateau circle, opens every session with some version of that, because almost everybody arrives with the opposite assumption already installed.

Where does that assumption come from? Mostly from a culture that treats bodies as machines that respond linearly to effort, and treats any deviation as a moral failing. It is nonsense as biology and it is corrosive as psychology, and it is the reason a plateau causes far more distress than the physiology alone would justify.

So this guide is about what is actually happening, what is worth looking at, and what is worth letting go of. It contains no targets and no numbers you are supposed to reach. If reading about this territory tends to send you somewhere unkind, body image and the media around this and support resources are both here, and there is no requirement to read this page at all.

What the trial curves actually look like

People are often startled by this, and it is genuinely reassuring: every weight-change curve in every one of these trials flattens.

In STEP 1 (Wilding, New England Journal of Medicine, 2021), the semaglutide curve descends steeply through the first months and then bends towards horizontal well before the trial ends at 68 weeks. In SURMOUNT-1 (Jastreboff, NEJM, 2022), the tirzepatide curves do the same thing, with the highest dose still moving slightly at 72 weeks but nothing like as steeply as at the start.

These are the flagship trials, in monitored populations, with the medication supplied and adherence supported. The plateau is in the data. It is not a deviation from the expected result; it is the expected result.

Which means, plainly, that if you have plateaued after some months, you are doing the thing the trial participants did. Nothing has gone wrong. Sunil, who is generally the sceptic in the room, says this is one of the few places where the trial evidence is unambiguously comforting, and that it is a shame nobody puts the graph in front of people at the start.

The physiology, without mysticism

Several things are happening at once, and none of them is your metabolism being "broken" — a phrase that circulates widely and describes nothing real.

A smaller body costs less to run. Less tissue is being maintained and less mass is being moved, so daily energy requirements fall. This is arithmetic, not sabotage.

Adaptive changes. Energy expenditure tends to fall somewhat more than size alone predicts, and hormonal signals of hunger and fullness shift in ways that resist further change. This has been described in humans for decades, long before these drugs existed, and these medicines appear to blunt but not abolish it.

The drug effect reaches its ceiling. Appetite suppression is not unlimited and does not accumulate forever. Once you are at a steady dose, you are at a steady effect.

Intake drifts upward, usually invisibly. Nausea settling, food becoming appealing again, portions creeping back towards normal. This is not cheating. It is often a sign that you feel better.

Ren, who runs the strength circle, adds the one that gets missed: some of the flattening is composition rather than mass. If you have been loading your muscles, the scale can sit still while quite a lot is changing underneath it — and keeping your strength is the part that pays off later.

What is worth actually checking

Not to break the plateau — to make sure nothing dull is being missed.

• Is it a plateau or is it measurement noise? Weight fluctuates by a surprising amount day to day with fluid, salt, hormones and gut transit. A fortnight of stillness is usually noise. Several months is a pattern. If daily weighing makes you miserable, weighing less often is a legitimate answer.
• Have you been eating enough, particularly protein? Under-eating during a period of appetite suppression is common and makes people feel dreadful without helping anything. Protein and strength and the target tool are the practical end.
• Sleep and shift patterns. Chronically short sleep affects appetite regulation measurably. See sleep and shift work.
• Anything new in the medicine cabinet? Several common medications affect weight. Worth a look with your prescriber rather than an assumption.
• Storage and handling. Rare, but real: product that has been through a heat excursion or frozen may not be doing what you think. Storage and the cold chain.
• Is anything else going on? Thyroid, new symptoms, a period of illness. Worth mentioning rather than assuming.

What we will not do is tell you to increase your dose. Dose decisions belong with your prescriber, and "I have plateaued" is a perfectly good thing to bring to them — alongside the honest question of whether increasing is the right move for you, which is not always yes.

The evidence about continuing

There is one piece of trial evidence that speaks fairly directly to this, and it is worth knowing.

STEP 4 (Rubino, JAMA, 2021) took people who had already completed twenty weeks of semaglutide and randomised them either to continue or to switch to placebo for a further 48 weeks. Those who continued lost a further amount on average; those switched to placebo regained. SURMOUNT-4 (Aronne, JAMA, 2024) ran a similar design with tirzepatide after a 36-week lead-in and found the same shape — continued treatment held and extended the change, withdrawal reversed much of it.

What that tells you is that the medicine is still doing something during the flat part of the curve, even when the scale is still. Holding position is an active result, not an absence of one. Members find this genuinely useful when they are being told, usually by someone with no stake in it, that a plateau means the drug has stopped working.

What it does not tell you is whether any particular change would restart movement for you. Neither trial tested that, and nobody should pretend otherwise.

The possibility nobody offers you

Here is the thought Ada finds most people have never been permitted to have: the plateau may be where your body has settled, and that may be the destination rather than a delay.

Maintenance is a real phase with its own skills, and it is the least written-about part of this whole business. We have a guide precisely because members kept arriving at it with no map — maintenance, the part nobody writes about — and a maintenance circle that is, tellingly, one of our quietest and steadiest.

The alternative to accepting a plateau is often an escalating effort that costs more than it returns: more restriction, more monitoring, more of the mental architecture that many of us came here to get away from. If you notice that a plateau is pushing you towards eating less than you need, weighing yourself many times a day, or thinking about this constantly, please read the warning signs guide. That pattern is common here and it is not a character flaw.

Noah wrote in his journal, at fourteen weeks of nothing moving: "I keep waiting for permission to be finished." He got it from a circle rather than from a clinic, which is not ideal, but it counted. Consider this page a second copy of that permission.